Re: Zenith share issue

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2647 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith share issue

in response to

Re: Zenith share issue

BearDownAZ

posted on Nov 14, 2017 01:11PM

would love to see a major deal with a BP but we have never had one to this point, It would hugely legitimize the science of Zenith and RVX and would be a good catalyst for share movement for RVX (IMO)

6 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply